Announcement on Convening Performance Briefing for 2025 and Q1 2026
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference: View Attachment
Announcement on Convening Performance Briefing for 2025 and Q1 2026
Filed with SSE ·
6ix hasn’t read this filing yet.
Autobio Diagnostics Co., Ltd. on 6ix
Earlier from Autobio Diagnostics
- Announcement on Implementation of Dividend Distribution for 2025
- Announcement on Company and Its Wholly-Owned Subsidiary Obtaining Medical Device Registration Certificate
- Announcement on Resolutions of the 2025 Annual General Meeting
- Announcement on Redemption of Using Idle Raised Funds for Cash Management
- Special Report on Deposit, Management and Actual Use of Raised Funds in 2025
Later from Autobio Diagnostics
- Announcement on Redemption and Progress of Using Idle Raised Funds for Cash Management
- Announcement on Cancellation of Medical Device Business License and Filing Record for Class II Medical Device Business by Second-Tier Subsidiary
- Announcement on Resolutions of the 13th Meeting of the 5th Board of Directors
- Announcement on Company and Its Second-Tier Subsidiary Obtaining Medical Device Registration Certificate
- Announcement on Redemption and Progress of Cash Management Using Idle Raised Funds
Follow Autobio Diagnostics into a list and get an email when it puts out news.
Follow Autobio Diagnostics